179 Direct Oral Anticoagulants in End State Renal Disease

179 Direct Oral Anticoagulants in End State Renal Disease

Saved in:

Bibliographic Details
Main Authors:	Avani Prabhu, Bhakti Singh, Anvi Peddi, Haritha Pabbathi, Atul Laddu, Jawed Fareed
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Research and Practice in Thrombosis and Haemostasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2475037925001530
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

181 History of the Introduction of Direct Oral Anticoagulants and Their Mechanism of Action
by: Arya Karmarkar, et al.
Published: (2025-05-01)

184 Worldwide Heparin Shortage
by: Maanas Deodhar, et al.
Published: (2025-05-01)

180 Elevation of D-Dimer Without Any Evidence of Venous Thromboembolism: What Is Your Interpretation?
by: Om Joshi, et al.
Published: (2025-05-01)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
by: Z. D. Kobalava, et al.
Published: (2021-03-01)

DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01)

185 The Youth is our Future, and the Future is Here
by: Omkar Garud, et al.
Published: (2025-05-01)

183 Women in Science
by: Isha Jayakumar, et al.
Published: (2025-05-01)

Direct oral anticoagulants for electrical cardioversion
by: A. N. Volovchenko, et al.
Published: (2021-07-01)

Direct Oral Anticoagulants in Cancer Patients
by: Nicolas Bonadies, et al.
Published: (2024-10-01)

Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants
by: A. I. Mironova, et al.
Published: (2022-06-01)

Direct-acting oral anticoagulants in antiphospholipid syndrome
by: T. M. Reshetnyak, et al.
Published: (2021-01-01)

Exploring the implications of direct oral anticoagulants in trauma
by: Vanessa P Ho, et al.
Published: (2024-07-01)

Use of direct oral anticoagulants in kidney diseases
by: I.A. Paliienko, et al.
Published: (2025-03-01)

Direct oral anticoagulant: Looking beyond convenience
by: Samuel Ji Quan Koh, et al.
Published: (2024-02-01)

Prophylactic and Therapeutic Anticoagulation in Nephrotic Syndrome Using Direct Acting Oral Anticoagulants
by: Donal J. Sexton, et al.
Published: (2025-04-01)

Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art
by: S. R. Gilyarevsky
Published: (2022-07-01)

Impact on Adherence and Clinical Outcomes of an Anticoagulation Stewardship Program in Users of Direct Oral Anticoagulants
by: Mayra A. Arenas-Beltrán, et al.
Published: (2025-04-01)

CONCERNING THE SAFETY OF THE DIRECT ORAL ANTICOAGULANTS IN ROUTINE CARE
by: Board Resolution Expert
Published: (2017-07-01)

On improving the safety of new direct acting oral anticoagulants
by: N. Yu. Velts, et al.
Published: (2018-02-01)

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
by: B. A. Tatarsky, et al.
Published: (2021-08-01)

Direct Oral Anticoagulants in Patients With ESRD and Kidney Transplantation
by: Nicholas W. Lange, et al.
Published: (2025-01-01)

Efficacy of direct oral anticoagulant for renal infarction due to pulmonary vein stump thrombosis after left pneumonectomy
by: Yoshihito Iijima, et al.
Published: (2022-12-01)

186 Anticoagulation Stewardship Using a Direct Oral Anticoagulation Dashboard to Reduce Incorrect Prescribing
by: Jeffrey Lee, et al.
Published: (2025-05-01)

Prognosis of Patients With Ischemic Stroke With Prior Anticoagulant Therapy: Direct Oral Anticoagulants Versus Warfarin
by: Kyeong‐Hyeon Chun, et al.
Published: (2024-08-01)

Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis—Where Do We Stand?
by: Nikhil Vojjala, et al.
Published: (2025-01-01)

WCN25-185 ASSOCIATION BETWEEN THROMBOINFLAMMATORY BIOMARKERS AND CELLULAR INDICES IN PATIENTS WITH END STAGE RENAL DISEASE
by: Vinod Bansal, et al.
Published: (2025-02-01)

WCN25-218 UPREGULATION OF TISSUE FACTOR IS ASSOCIATED WITH INCREASED LEVELS OF D-DIMER AND DECREASED LEVELS OF THROMBIN GENERATION IN END-STAGE RENAL DISEASE
by: Vinod Bansal, et al.
Published: (2025-02-01)

Is there still room for warfarin after the appearance of direct oral anticoagulants?
by: E. P. Panchenko
Published: (2023-01-01)

Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding
by: A. B. Sumarokov, et al.
Published: (2019-01-01)

Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
by: Mahmoud Abdelnabi, et al.
Published: (2020-02-01)

Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01)

Renal Outcomes of Novel Oral Anticoagulants Among Patients With Atrial Fibrillation
by: Yik Ching Hung, et al.
Published: (2025-06-01)

WCN25-214 CELLULAR INDICES IN RELATION WITH D-DIMER AND THROMBIN LEVELS IN PATIENTS WITH END STAGE RENAL DISEASE
by: Vinod Bansal, et al.
Published: (2025-02-01)

Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation
by: S. V. Malchikova, et al.
Published: (2020-08-01)

Direct Oral Anticoagulants Versus Traditional Anticoagulation in Cirrhotic Patients with Portal Vein Thrombosis: Updated Systematic Review
by: Xiulin Xiao M.S., et al.
Published: (2024-11-01)

156 Continued Assessment of a Direct Oral Anticoagulant (DOAC) Dashboard
by: Nghi Ha, et al.
Published: (2025-05-01)

Nephrotic Syndrome Thromboprophylaxis With Direct Oral Anticoagulants or Vitamin K Antagonists
by: Edouard Cubilier, et al.
Published: (2025-05-01)

A summary overview of the new, direct, target-specific oral anticoagulants
by: G. L. Muntingh
Published: (2016-08-01)

Role of Direct Oral Anticoagulants for Post-operative Venous Thromboembolism Prophylaxis
by: Han Naung Tun, et al.
Published: (2022-05-01)

Cost-effectiveness of direct oral anticoagulants in non-valvular atrial fibrillation
by: Inigo Gorostiza, et al.
Published: (2025-01-01)